15 results
8-K
EX-10.1
CNSP
CNS Pharmaceuticals, Inc.
30 Jul 24
Entry into a Material Definitive Agreement
7:00am
, or the use of such Licensed Product by any customer of any of the foregoing, infringes proprietary rights of a Third Party, the Company shall give written
424B5
CNSP
CNS Pharmaceuticals, Inc.
26 Jul 24
Prospectus supplement for primary offering
8:30am
-dealer, at least two business days prior to a transaction in a penny stock not otherwise exempt from those rules, to deliver to the customer … a standardized risk disclosure document containing specified information and to obtain from the customer a signed and date acknowledgment of receipt
8-K
EX-1.1
CNSP
CNS Pharmaceuticals, Inc.
26 Jul 24
Entry into a Material Definitive Agreement
8:00am
combinations or strategic alliances, vendor, consultant, customer or other comparable transactions occurring after the date of this Agreement which
424B4
CNSP
CNS Pharmaceuticals, Inc.
31 Jan 24
Prospectus supplement with pricing info
4:27pm
customer needs and any measures they may have in place may not be adequate to recover production processes quickly enough to support critical timelines
8-K
EX-1.1
sz313ahlxi05afwl hx
12 Feb 21
Entry into a Material Definitive Agreement
5:13pm
S-8
EX-99.1
xzip6e4i
22 Jul 20
Registration of securities for employees
8:51am
10-K
5lnxnv1uz8i8f
12 Mar 20
Annual report
4:06pm
S-1/A
EX-1.1
gb3imxd02tm
16 Jul 19
IPO registration (amended)
1:23pm
- Prev
- 1
- Next